Zens Health Care Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 11 Year, 2 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 442.86%
(FY 2023)
- Profit 904.81%
(FY 2023)
- Ebitda 865.90%
(FY 2023)
- Net Worth 161.56%
(FY 2023)
- Total Assets 147.06%
(FY 2023)
About Zens Health Care
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Himanshu Garg and Khajanchi Lal serve as directors at the Company.
- CIN/LLPIN
U24233DL2014PTC263691
- Company No.
263691
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jan 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Zens Health Care Private Limited offer?
Zens Health Care Private Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Cefpodoxime Proxetil Capsules, Cefixime Ofloxacin Tablets, Pantoprazole Drugs, Pantoprazole Tablets, Antibiotic Injection, Ceftriaxone and Sulbactam Injection, Antipyretic Medication, Mefenamic Paracetamol Syrup, Protein Powder.
Who are the key members and board of directors at Zens Health Care?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshu Garg  | Director | 17-Jan-2014 | Current |
| Khajanchi Lal | Director | 05-Dec-2015 | Current |
Financial Performance of Zens Health Care.
Zens Health Care Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 442.86% increase. The company also saw a substantial improvement in profitability, with a 904.81% increase in profit. The company's net worth Soared by an impressive increase of 161.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zens Health Care?
In 2023, Zens Health Care had a promoter holding of 66.67% and a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zens Health Care?
Unlock and access historical data on people associated with Zens Health Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zens Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zens Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
